Dapagliflozin Propanediol Monohydrate (Eq. to Dapagliflozin 10mg) + Metformin HCl 500mg (SR) is a combination medication used to manage type 2 diabetes mellitus by controlling blood sugar levels.

Dapagliflozin (10mg) is an SGLT2 inhibitor that works by blocking the sodium-glucose co-transporter 2 in the kidneys, preventing glucose reabsorption and promoting its excretion in the urine. This helps lower blood sugar levels and also provides benefits in heart failure and chronic kidney disease.

Metformin HCl (500mg, SR) is a biguanide that improves insulin sensitivity, reduces glucose production in the liver, and increases glucose uptake by muscles. The sustained-release (SR) formulation ensures a slower release of the medication, which helps reduce gastrointestinal side effects and provides a more consistent blood glucose-lowering effect throughout the day.

This combination provides dual action to help control blood sugar levels in patients with type 2 diabetes. Dapagliflozin works by reducing blood sugar through urinary glucose excretion, while Metformin enhances insulin sensitivity and decreases liver glucose production.